The Cigna Group's Evernorth division is investing $100 million through 2028 to develop an AI-powered specialty pharmacy program. This initiative, named "Pharmacy Forward," aims to enhance patient access to and experience with specialty medications, particularly for complex conditions and high-cost drugs like GLP-1s. The program will initially launch with Accredo Specialty Pharmacy, leveraging AI and real-time data to provide more personalized, proactive support and improve prescription delivery efficiency. AI
IMPACT This investment could accelerate the adoption of AI in healthcare logistics and patient support, potentially improving efficiency and outcomes for specialty drug delivery.
RANK_REASON Significant investment by a major health services business into an AI-powered program. [lever_c_demoted from significant: ic=1 ai=0.7]
- Accredo Specialty Pharmacy
- CVS Health
- Evernorth
- GLP-1
- Katya Andresen
- Matt Perlberg
- Pharmacy Forward
- The Cigna Group
- Walgreens Boots Alliance
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
